Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bidyadhar Sethy

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Cell and Developmental Biology|October 5, 2020
Recent Update of HDAC Inhibitors in LymphomaI-Chung Chen, Bidyadhar Sethy, Jing-Ping Liou
Viruses|September 28, 2021
Identification of Potential Drug Targets of Broad-Spectrum Inhibitors with a Michael Acceptor Moiety Using Shotgun ProteomicsHao-Wei Chu, Bidyadhar Sethy, Pei-Wen Hsieh, et al.
Future Medicinal Chemistry|May 11, 2018
Design, synthesis & structure-activity relationships of a new class of antihuman enterovirus D68 & A71 agentsBidyadhar Sethy, Chung-Fan Hsieh, Chieh Yeh, et al.
Apoptosis : an International Journal on Programmed Cell Death|October 12, 2024
Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancerBidyadhar Sethy, Richa Upadhyay, Iin Narwanti, et al.
Bioorganic Chemistry|September 19, 2024
Design, synthesis, and biological evaluation of adenosine derivatives targeting DOT1L and HAT as anti-leukemia agentsBidyadhar Sethy, Zih-Yao Yu, Iin Narwanti, et al.
Bioorganic & Medicinal Chemistry Letters|February 11, 2025
Isolation, synthesis and structure-activity relationships of gallotannin derivatives as cathepsin C inhibitorHung-Chen Liao, Liang-Mou Kuo, Wei-Ting Chen, et al.
European Journal of Medicinal Chemistry|June 11, 2023
6-Regioisomeric 5,8-quinolinediones as potent CDC25 inhibitors against colorectal cancersIin Narwanti, Zih-Yao Yu, Bidyadhar Sethy, et al.
European Journal of Medicinal Chemistry|October 4, 2025
Quinoline-5,8-dione CDC25 inhibitors: Potent anti-cancer agents in leukemia and patient-derived colorectal organoidsIin Narwanti, Zih-Yao Yu, Bidyadhar Sethy, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 21, 2025
A novel quinoid-based CDC25 phosphatase inhibitor against human lung adenocarcinoma across different modelsTsung-Ching Lai, Iin Narwanti, Bidyadhar Sethy, et al.
Journal of Medicinal Chemistry|February 13, 2019
Design, Synthesis, and Biological Evaluation of Itaconic Acid Derivatives as Potential Anti-Influenza AgentsBidyadhar Sethy, Chung-Fan Hsieh, Ta-Jen Lin, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Cell and Developmental Biology|October 5, 2020
Recent Update of HDAC Inhibitors in LymphomaI-Chung Chen, Bidyadhar Sethy, Jing-Ping Liou
Viruses|September 28, 2021
Identification of Potential Drug Targets of Broad-Spectrum Inhibitors with a Michael Acceptor Moiety Using Shotgun ProteomicsHao-Wei Chu, Bidyadhar Sethy, Pei-Wen Hsieh, et al.
Future Medicinal Chemistry|May 11, 2018
Design, synthesis & structure-activity relationships of a new class of antihuman enterovirus D68 & A71 agentsBidyadhar Sethy, Chung-Fan Hsieh, Chieh Yeh, et al.
Apoptosis : an International Journal on Programmed Cell Death|October 12, 2024
Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancerBidyadhar Sethy, Richa Upadhyay, Iin Narwanti, et al.
Bioorganic Chemistry|September 19, 2024
Design, synthesis, and biological evaluation of adenosine derivatives targeting DOT1L and HAT as anti-leukemia agentsBidyadhar Sethy, Zih-Yao Yu, Iin Narwanti, et al.
Bioorganic & Medicinal Chemistry Letters|February 11, 2025
Isolation, synthesis and structure-activity relationships of gallotannin derivatives as cathepsin C inhibitorHung-Chen Liao, Liang-Mou Kuo, Wei-Ting Chen, et al.
European Journal of Medicinal Chemistry|June 11, 2023
6-Regioisomeric 5,8-quinolinediones as potent CDC25 inhibitors against colorectal cancersIin Narwanti, Zih-Yao Yu, Bidyadhar Sethy, et al.
European Journal of Medicinal Chemistry|October 4, 2025
Quinoline-5,8-dione CDC25 inhibitors: Potent anti-cancer agents in leukemia and patient-derived colorectal organoidsIin Narwanti, Zih-Yao Yu, Bidyadhar Sethy, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 21, 2025
A novel quinoid-based CDC25 phosphatase inhibitor against human lung adenocarcinoma across different modelsTsung-Ching Lai, Iin Narwanti, Bidyadhar Sethy, et al.
Journal of Medicinal Chemistry|February 13, 2019
Design, Synthesis, and Biological Evaluation of Itaconic Acid Derivatives as Potential Anti-Influenza AgentsBidyadhar Sethy, Chung-Fan Hsieh, Ta-Jen Lin, et al.
Pageof 2